EmOpti Revenue and Competitors

Brookfield, WI USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • EmOpti's estimated annual revenue is currently $1.3M per year.(i)
  • EmOpti's estimated revenue per employee is $84,000

Employee Data

  • EmOpti has 15 Employees.(i)
  • EmOpti grew their employee count by -12% last year.

EmOpti's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director Software Engineering / Chief ArchitectReveal Email/Phone
3
Director, Product ManagementReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Director Business DevelopmentReveal Email/Phone
6
Director, Operations and Professional Services - Provider Network (Health and Wellness)Reveal Email/Phone
7
Implementation SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16M114-6%$98.3MN/A
#2
$0M2-33%$17.9MN/A
#3
$21.7M14113%N/AN/A
#4
$37.2M247-13%$95MN/A
#5
$1.5M18-40%N/AN/A
#6
$38.5M25039%N/AN/A
#7
$1.3M15-12%N/AN/A
#8
$40.5M26328%N/AN/A
#9
$91.5M523N/AN/AN/A
#10
$0M2-50%$26.4MN/A
Add Company

What Is EmOpti?

EmOpti provides innovative analytics, telemedicine technologies, and command center coordination to optimize both clinical and financial performance across the spectrum of acute care medicine. EmOpti partners with hospital systems and existing providers to help them deliver care in new ways resulting in improved performance metrics as well as delighted patients and staff.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$1.3M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EmOpti News

2022-04-19 - Patient Flow Management Solutions Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Type, Component ; and Delivery Mode and Geography

EmOpti, a company established in the US, provides a telehealth platform compatible with patient electronic health information (EHR).

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M1525%N/A
#2
$1.3M15-6%N/A
#3
$1.6M180%N/A
#4
$1.7M19-10%N/A
#5
$2.2M20-29%N/A